Mirae Asset Global Investments »

Crispr Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.6M 90k 62.60
2023-09-30 $8.4M 185k 45.39
2023-06-30 $9.4M 168k 56.14
2023-03-31 $7.7M 171k 45.23
2022-12-31 $6.7M 164k 40.65
2022-09-30 $11M 169k 65.35
2022-06-30 $9.0M 148k 61.06
2022-03-31 $6.6M 105k 62.83
2021-12-31 $9.4M 125k 75.52
2021-09-30 $12M 72k 161.53
2021-06-30 $12M 72k 161.53
2021-03-31 $8.7M 72k 121.86
2020-12-31 $6.0M 40k 153.10
2020-09-30 $3.3M 39k 83.65
2020-06-30 $2.0M 27k 73.49
2020-03-31 $520k 12k 42.39
2019-12-31 $664k 11k 60.61
2019-09-30 $380k 9.3k 40.98